All articles by Sarah Houlton – Page 5
-
BusinessRoche to buy InterMune for respiratory boost
$8.3bn deal gives Roche a leading position in pulmonary fibrosis
-
Business
Amgen to shed 2400-2900 jobs
Restructuring will see three sites close as company comes under pressure to streamline R&D, despite successes
-
CareersWest side stories
A stint in a US chemistry lab is a rite of passage for many academics. Sarah Houlton talks to the chemists who went to the labs of opportunity
-
FeatureTriple-stranded success story
Tom Brown is our Entrepreneur of the Year. He tells Sarah Houlton the secrets of his success
-
CareersRemote possibilities
Now you can graduate in drug discovery without ever leaving the house, as Sarah Houlton finds out
-
FeatureScience at your fingertips
Will the rise of smartphones revolutionise chemistry? Sarah Houlton finds out
-
BusinessMegamerger brings Actavis into R&D race
$25bn Forest Labs takeover will see generics giant take on patented products
-
-
CareersThe pain killer
Life is pretty painless working in Reckitt Benckiser’s Nurofen team, Sarah Houlton learns
-
BusinessMis-selling lands J&J with $2.2bn fine
Company found guilty of promoting three drugs for unapproved uses
-
CareersThe plastics surgeon
Sarah Houlton takes a ‘Peek’ at the career of polymer chemist Alice Matthews
-
BusinessPharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
Business
Amgen snaps up Onyx in huge biotech deal
$10.4 billion acquisition will expand firm’s oncology portfolio
-
CareersLearn to speak engineering
Chemists and chemical engineers are two groups separated by a common science. Sarah Houlton looks at a course that’s bridging the gap
-
CareersGoing with the flow chemistry
Elizabeth Farrant climbed to the top in big pharma, but now she’s working at a smaller scale, as Sarah Houlton finds out
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
Business
GSK fires Chinese R&D head in data investigation
Company is retracting a 2010 study in which data were ‘misrepresented’
-
FeatureNo small success
Chad Mirkin has spun out his nanotechnology research into several companies
-
BusinessThermo Fisher to buy Life Technologies in $15.8bn deal
Equipment suppliers unite, bringing Thermo into life sciences and sequencing markets
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec